Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 21, 2011 08:00 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma's Ampligen(R) Tested in Combination With Experimental Vaccine From Leading Cancer Research Institute

PHILADELPHIA, June 21, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company" or "Hemispherx") today announced that it has entered into a Material Transfer and Research...